Gilead Sciences (NQ:GILD)

144.63 -0.11 (-0.08%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gilead Sciences

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

78 79 Next >

Moderna (MRNA) Q4 Earnings Report Preview: What To Look For

February 13, 2025

Biotechnology company Moderna (NASDAQ:MRNA) will be announcing earnings results tomorrow before market open. Here’s what to expect.

Via StockStory

Top S&P500 movers in Wednesday's session ↗

February 12, 2025

Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch For HIV Prevention ↗

February 12, 2025

Gilead reported Q4 adjusted EPS of $1.90, exceeding estimates, with HIV sales up 16%. The company raised guidance and expects a key HIV drug launch in 2025.

Via Benzinga

These S&P500 stocks have an unusual volume in today's session ↗

February 12, 2025

Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Wednesday. Stay informed about the market activity below.

Via Chartmill

Why Gilead Sciences (GILD) Stock Is Trading Up Today

February 12, 2025

Shares of biopharmaceutical company Gilead Sciences (NASDAQ:GILD) jumped 8.6% in the morning session after the company reported impressive fourth-quarter results that exceeded analysts' revenue, EPS,...

Via StockStory

Why Gilead Sciences Stock Is Jumping Today ↗

February 12, 2025

Via The Motley Fool

These S&P500 stocks are moving in today's session ↗

February 12, 2025

Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday? ↗

February 12, 2025

A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New...

Via Benzinga

Topics Economy

Gilead Sciences, Upstart, Mercury General, Confluent And Other Big Stocks Moving Higher On Wednesday ↗

February 12, 2025

Via Benzinga

Gilead Sciences Options Trading: A Deep Dive into Market Sentiment ↗

February 10, 2025

Via Benzinga

Discover the top S&P500 movers in Wednesday's pre-market session. ↗

February 12, 2025

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

Gilead Wins Price-Target Boosts After Solid Q4, Retail Brushes Off Medicare Reform Hit To HIV Drugs ↗

February 12, 2025

Investors seem encouraged by the company's strong performance in its core business areas and the promise of further growth driven by its expanding pipeline.

Via Stocktwits

Markets Mixed On Powell Testimony, Q4 Earnings ↗

February 11, 2025

Market indexes were mixed today, after seeing all the majors in the red before the opening bell. The Dow closed up +123 points, +0.28%, while the S&P 500 squeaked by +2 points.

Via Talk Markets

Topics Stocks Stocks / Equities

Gilead Sciences (GILD) Q4 2024 Earnings Call Transcript ↗

February 11, 2025

GILD earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Gilead Sciences Shares Push Higher After Q4 Report: Here's Why ↗

February 11, 2025

Gilead Sciences reported its fourth-quarter financial results after Tuesday's closing bell. Here's a look at the highlights from the report:

Via Benzinga

Gilead Sciences Beats Q4 EPS Forecast ↗

February 11, 2025

Gilead Sciences reported strong fourth-quarter earnings with significant growth in its HIV and oncology segments.

Via The Motley Fool

Gilead Sciences (NASDAQ:GILD) Delivers Strong Q4 Numbers

February 11, 2025

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 6.4% year on year to $7.57 billion. The company expects the full...

Via StockStory

Gilead Outplays Veklury Downfall To Obliterate Forecasts. Will Shares Win Back Their Breakout? ↗

February 11, 2025

Gilead obliterated fourth-quarter expectations Tuesday and issued an upbeat profit outlook for 2025.

Via Investor's Business Daily

Gilead Sciences Announces 2.6 Percent Increase in First Quarter 2025 Dividend

February 11, 2025

From Gilead Sciences, Inc.

Via Business Wire

Gilead Sciences Announces Fourth Quarter and Full Year 2024 Financial Results

February 11, 2025

From Gilead Sciences, Inc.

Via Business Wire

US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday? ↗

February 11, 2025

U.S.

Via Benzinga

US Stock To Likely Open Lower Amid Tariff Tensions: Expert Hints Sans Lower Tariffs It's Hard To See The 'Market Going Up' ↗

February 11, 2025

U.S. stock futures fell on Tuesday after ending higher on Monday a revenue miss from McDonald's Corp and weak ON Semiconductor Corp earnings.

Via Benzinga

Nasdaq Gains 1% As Nvidia, Broadcom Surge: Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone ↗

February 11, 2025

The CNN Fear and Greed Index improved to Neutral zone on Monday with the overall market sentiment improving. U.S. stocks closed higher, led by tech gains.

Via Benzinga

Coca-Cola, Marriott International And 3 Stocks To Watch Heading Into Tuesday ↗

February 11, 2025

Via Benzinga

Markets Steady, Positive; Q4 Earnings Keep Rolling ↗

February 10, 2025

Markets were flat but positive in an initial trading day for a new week, basically shrugging off whatever warning signs may have been considered regarding President Trump’s 25% steel tariff headline...

Via Talk Markets

Topics Government Stocks / Equities World Trade

Earnings Scheduled For February 11, 2025 ↗

February 11, 2025

Via Benzinga

Healthcare And Biotech Playbook As Disruption Gathers Force ↗

February 10, 2025

The XBI was down 1.54% for the week, like off a cliff on Friday from a Wednesday high of $94.82.

Via Talk Markets

Topics ETFs Stocks / Equities

What To Expect When Biotech Giant Gilead Reports Q4 Earnings On Tuesday? ↗

February 10, 2025

Gilead reports Q4 earnings on Feb. 11. Analysts expect $1.70 EPS. The LEO Pharma deal could reduce 2025 EPS by up to $0.17.

Via Benzinga

Gilead Sciences (GILD) Q4 Earnings: What To Expect

February 10, 2025

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be announcing earnings results tomorrow afternoon. Here’s what to expect.

Via StockStory

3 Fabulous Dividend Stocks to Buy in February ↗

February 09, 2025

Via The Motley Fool

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

78 79 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.